Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Open in API
Filings indexed 3,374 across all filing types
Latest filing 2021-12-10 Board/Management Inform…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions, including committee memberships. It does not contain financial data, earnings, or report content. It is an announcement related to the company's board structure and management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board composition, confirming this classification.
2021-12-10 English
APPOINTMENT AND RESIGNATION OF NON-EXECUTIVE DIRECTORS
Board/Management Information Classification · 100% confidence The document is an announcement from CStone Pharmaceuticals regarding the appointment and resignation of non-executive directors. It details the background of the newly appointed director, Mr. Kenneth Walton Hitchner III, and the resignation of Mr. Qun Zhao. There is no financial data, no mention of financial results, reports, or regulatory filings beyond the director changes. The content focuses solely on board/management changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 7416 characters, which is sufficient for a detailed announcement but does not contain financial statements or other report types.
2021-12-10 English
ARTICLES OF ASSOCIATION OF YANKUANG ENERGY GROUP COMPANY LIMITED
Governance Information Classification · 100% confidence The document is titled 'Articles of Association of Yankuang Energy Group Company Limited' and contains detailed chapters on company governance, share structure, board of directors, shareholder rights, and other corporate governance matters. It is a comprehensive legal document outlining the internal rules and governance framework of the company. There is no indication that this is an annual report, financial statement, or any other type of financial or regulatory filing. The content aligns with the definition of Governance Information, which covers the company's internal rules, board structure, and governance practices. The document length is substantial (15,000 characters), indicating it is the full Articles of Association, not a brief announcement or summary. Therefore, the appropriate classification is Governance Information (CGR).
2021-12-06 English
CHANGE OF COMPANY NAME, FILINGS OF ARTICLES OF ASSOCIATION AND CHANGE OF A SHARE STOCK SHORT NAME
Board/Management Information Classification · 95% confidence The document is an announcement regarding the change of the company's name, filings of amended Articles of Association, and change of the A Share stock short name. It references previous announcements and resolutions but does not contain financial statements, audit information, or detailed financial data. The document is relatively short (4484 characters) and serves as a formal notification of corporate changes rather than a report or detailed presentation. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is also not a regulatory certification or legal proceeding update. The content is about corporate governance changes, specifically company name and stock short name changes, which aligns with Board/Management Information filings. Therefore, the most appropriate classification is MANG (Board/Management Information).
2021-12-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2021
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return on movements in securities, specifically focusing on share capital, issued shares, share options, and confirmations related to securities issued by the company CStone Pharmaceuticals. It includes data on authorized and issued shares, share option schemes, and confirmations by a director. The document is submitted to the Hong Kong Exchanges and Clearing Limited and relates to share capital changes and share issuance activities. This type of document fits the category of Share Issue/Capital Change announcements, as it reports on changes in share capital and share issuance during the month. It is not a full financial report, earnings release, or management discussion, but a regulatory filing about share capital movements.
2021-12-06 English
Monthly Returns
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 30 November 2021. It details movements in authorised/registered share capital, issued shares, share options, and confirms no new securities were issued during the month. The content is focused on share capital and share issuance movements, with no financial statements or earnings data. It is a regulatory submission related to share capital movements and confirmations to the Hong Kong Exchanges and Clearing Limited. This type of document fits best under 'Share Issue/Capital Change' (SHA) as it reports on share capital and share issuance changes.
2021-12-05 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.